KiSS1-induced GPR54 signaling inhibits breast cancer cell migration and epithelial-mesenchymal transition via protein kinase D1

  • K. Tan
  • , S. G. Cho
  • , W. Luo
  • , T. Yi
  • , X. Wu
  • , S. Siwko
  • , M. Liu
  • , W. Yuan*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

The metastasis suppressor protein Kisspeptin regulates cancer cell proliferation and motility through its receptor, GRP54. However, the critical downstream effectors remain unclear. In this study, we investigated GPR54 signaling in breast cancer cells. Kisspeptin stimulation caused a decrease in migration of multiple breast cancer cell lines. Also, Kisspeptin inhibited MDA-MB-231 cell colony formation in 3D matrigel culture and in soft agar. Kisspeptin treatment elevated phosphorylated PKD1 in a PKC-dependent manner. However, knockdown of either GPR54 or PKD1 increased breast cancer cell migration and invasion. Furthermore, GPR54 knockdown blocked Kisspeptin-induced phosphorylation of PKD1. Finally, Kisspeptin stimulation induced a PKD1 phosphorylation-dependent decrease in expression of Slug, a transcription factor that drives epithelial-mesenchymal transition (EMT), and a concomitant increase in E-cadherin expression. Therefore, KiSS1/GPR54 signaling through PKD1 acts to maintain the epithelial state and to inhibit breast cancer cell invasiveness, and exerts functions associated with its role as a metastasis suppressor.

Original languageEnglish
Pages (from-to)652-662
Number of pages11
JournalCurrent Molecular Medicine
Volume14
Issue number5
DOIs
StatePublished - 2014
Externally publishedYes

Keywords

  • Breast cancer
  • G protein coupled receptors (GPCR)
  • GPR54
  • Invasion
  • KiSS1
  • Migration
  • Protein kinase D (PKD)

Fingerprint

Dive into the research topics of 'KiSS1-induced GPR54 signaling inhibits breast cancer cell migration and epithelial-mesenchymal transition via protein kinase D1'. Together they form a unique fingerprint.

Cite this